Search research articles
Contact Us
Filters
Showing results (61-70 of 78) with videos related to
Page
of 8
Sort By:
Journal of Cellular Biochemistry
|
March 21, 2000
Inhibition of neointima formation by a nonpeptide alpha(v)beta(3) integrin receptor antagonist in a rabbit cuff model
A L Racanelli, S K Gibbs, K L Schlingmann, et al.
Circulation
|
February 1, 1996
Oral antiplatelet, antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa antagonist
S A Mousa, W F DeGrado, D X Mu, et al.
Thrombosis Research
|
July 1, 1993
Recombinant plasminogen activator inhibitor-1 protects platelets against the inhibitory effects of plasmin
T M Reilly, M S Forsythe, A L Racanelli, et al.
Biochemical and Biophysical Research Communications
|
October 31, 1989
Monoclonal antibodies directed against basic fibroblast growth factor which inhibit its biological activity in vitro and in vivo
T M Reilly, D S Taylor, W F Herblin, et al.
Cardiovascular Research
|
April 16, 1998
Selective alpha v beta 3 integrin blockade potently limits neointimal hyperplasia and lumen stenosis following deep coronary arterial stent injury: evidence for the functional importance of integrin alpha v beta 3 and osteopontin expression during neointima formation
S S Srivatsa, L A Fitzpatrick, P W Tsao, et al.
The Journal of Biological Chemistry
|
June 5, 1990
Purification and characterization of recombinant plasminogen activator inhibitor-1 from Escherichia coli
T M Reilly, R Seetharam, J L Duke, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 11, 1998
Antiplatelet efficacy of XV459, a novel nonpeptide platelet GPIIb/IIIa antagonist: comparative platelet binding profiles with c7E3
S A Mousa, J M Bozarth, W Lorelli, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
December 1, 1995
A monoclonal antibody that recognizes the GPIIb/IIIa antagonist DMP 728. Reversal of the effects of DMP 728 on platelet aggregation and bleeding time in the dog
T M Reilly, S A Mousa, A L Racanelli, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
October 1, 1992
Effect of thrombin inhibitors on platelet functions: comparative analysis of DuP 714 and hirudin
T M Reilly, R M Knabb, S M Hassell, et al.
Biochemical and Biophysical Research Communications
|
September 30, 1991
Inhibition of the thrombin-platelet reactions by DuP 714
A T Chiu, S A Mousa, L J Pease, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 78) with videos related to
Sort By:
Page
of 8
Journal of Cellular Biochemistry
|
March 21, 2000
Inhibition of neointima formation by a nonpeptide alpha(v)beta(3) integrin receptor antagonist in a rabbit cuff model
A L Racanelli, S K Gibbs, K L Schlingmann, et al.
Circulation
|
February 1, 1996
Oral antiplatelet, antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa antagonist
S A Mousa, W F DeGrado, D X Mu, et al.
Thrombosis Research
|
July 1, 1993
Recombinant plasminogen activator inhibitor-1 protects platelets against the inhibitory effects of plasmin
T M Reilly, M S Forsythe, A L Racanelli, et al.
Biochemical and Biophysical Research Communications
|
October 31, 1989
Monoclonal antibodies directed against basic fibroblast growth factor which inhibit its biological activity in vitro and in vivo
T M Reilly, D S Taylor, W F Herblin, et al.
Cardiovascular Research
|
April 16, 1998
Selective alpha v beta 3 integrin blockade potently limits neointimal hyperplasia and lumen stenosis following deep coronary arterial stent injury: evidence for the functional importance of integrin alpha v beta 3 and osteopontin expression during neointima formation
S S Srivatsa, L A Fitzpatrick, P W Tsao, et al.
The Journal of Biological Chemistry
|
June 5, 1990
Purification and characterization of recombinant plasminogen activator inhibitor-1 from Escherichia coli
T M Reilly, R Seetharam, J L Duke, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 11, 1998
Antiplatelet efficacy of XV459, a novel nonpeptide platelet GPIIb/IIIa antagonist: comparative platelet binding profiles with c7E3
S A Mousa, J M Bozarth, W Lorelli, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
December 1, 1995
A monoclonal antibody that recognizes the GPIIb/IIIa antagonist DMP 728. Reversal of the effects of DMP 728 on platelet aggregation and bleeding time in the dog
T M Reilly, S A Mousa, A L Racanelli, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
October 1, 1992
Effect of thrombin inhibitors on platelet functions: comparative analysis of DuP 714 and hirudin
T M Reilly, R M Knabb, S M Hassell, et al.
Biochemical and Biophysical Research Communications
|
September 30, 1991
Inhibition of the thrombin-platelet reactions by DuP 714
A T Chiu, S A Mousa, L J Pease, et al.
Page
of 8